Study authors initiated this study because of a lack of data on arrhythmia trends among pregnant women who have been hospitalized for delivery, accounting for their age, comorbidities, and obesity status.
The incidence of pregnancy-related complications was higher among a cohort of pregnant patients hospitalized for delivery who had a history of arrhythmias, and these negative outcomes were influenced by all-cause in-hospital mortality, cardiovascular disease, and adverse pregnancy outcomes.
Study findings published in Frontiers in Cardiovascular Medicine also show negative outcomes are more likely among this patient subgroup when they are older than 35 years, are classified as obese, and have hypertension, valvular heart disease, or severe pulmonary disease because they have a greater chance of also having a history of arrhythmias or a delivery-induced arrhythmia.
“Although many arrhythmias during pregnancy have been considered benign, there is also limited data suggesting a relationship with in-hospital death,” the study authors wrote. “There is also little data associating arrhythmias with comorbidities and risk factors.”
Data on delivery hospitalizations from 2009 to 2019 from the National Inpatient Sample (NIS) database were used for this analysis, and International Classification of Diseases, 9th Edition and 10th Edition codes identifying supraventricular tachycardias (SVT), atrial fibrillation (AF), atrial flutter, ventricular tachycardia (VT), and ventricular fibrillation. There were 41 million–plus delivery hospitalizations analyzed.
SVTs were the most common arrhythmia seen (53%), followed by AF (31%) and VT (13%). The authors determined several factors related a potential link between delivery complications and increased risk of arrhythmias, and these were the following:
In addition, arrythmia-complicated hospital deliveries had higher rates of all-cause mortality, need for cardiogenic shock, preeclampsia, and preterm labor compared with women who did not have arrythmias (all P < .0001):
Delivery outcomes associated with arrythmias were also potential linked to older age, race/ethnicity, rural vs urban location, and insurance status:
Arrythmia-complicated deliveries vs women with no arrhythmias were also more than twice as likely if patients had these risk factors: obesity (16.95% vs 8.31%), hypertension (6.19% vs 1.53%), type 2 diabetes (1.39% vs 0.64%), MI history (0.22% vs 0.01%), PVD (0.23% vs 0.01%), and hyperlipidemia (0.35% vs 0.06%).
Risk behaviors were also more prevalent among the women with arrythmias, and these included tobacco use and substance abuse. Presence of comorbidities were also more common in women with arrhythmias, with the top 3 being chronic obstructive pulmonary disease, fluid and electrolyte disorders, and coagulopathy, respectively.
“These findings build upon previously published studies, which have all shown an increased frequency of arrhythmias in pregnant women since the 1990s. The measured rise in prevalence of arrhythmias during pregnancy is likely multifactorial,” the study authors wrote. “While the increased prevalence could be partially the result of a rise in risk factors, such an increase could be also be due to greater use of electronic medical records, remote monitoring, and overall shifts in monitoring and recording practices.”
They stressed the importance of multidisciplinary care and preventive cardiology prevention among women with known cardiovascular disease or who may be at higher risk for it, with cardio-obstetric care known to reduce cardiac maternal morbidity.
“Management of arrhythmia must occur at every stage of pregnancy,” they concluded, “from prevention to early recognition of complications during delivery.”
Reference
Thakkar A, Kwapong YA, Patel H, et al. Temporal trends of arrhythmias at delivery hospitalizations in the United States: Analysis from the National Inpatient Sample, 2009-2019. Front Cardiovasc Med. Published online November 3, 2022. doi:10.3389/fcvm.2022.1000298
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
California Aims for Equity by Redefining Cancer Care
December 8th 2023Authors highlight key aspects of the California Cancer Care Equity Act, including its focus on Medi-Cal beneficiaries, the requirement for managed care plans to contract with specialized cancer centers, and the definition of complex cancers.
Read More
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
Patients With RA in Remission Withdrawing From TNF Inhibition Show Flare Increases
December 8th 2023New data presented at ACR 2023 highlighted the differences in rates of flares and Boolean 2.0 remission rates compared to patients with rheumatoid arthritis who continued a tumor necrosis factor inhibitor (TNFi).
Read More
New Insights on Breast Cancer Outcomes Among Sexual, Gender Minorities
December 7th 2023Despite there being a great demand for data collection on sexual orientation and gender identity in the cancer space, individuals who identify as a sexual and gender minority remain poorly represented.
Read More